Oral clomiphene citrate and vaginal progesterone suppositories in the treatment of luteal phase dysfunction: a comparative study

Fertility and sterility, 51(1), 35-41

DOI 10.1016/s0015-0282(16)60424-7 PMID 2910717 Source

Abstract

Oral clomiphene citrate (CC) and vaginal progesterone suppositories (PS) are common treatment modalities in luteal phase dysfunction (LPD). Little is known regarding the relative efficacy of these agents. To study the use of CC and PS in the management of LPD, a retrospective cohort study of patients presenting with infertility was undertaken. Sixty-five patients in whom LPD was diagnosed and corrected, as judged by endometrial biopsies, were studied; 35 were treated with PS and 30 with CC. Using Student's t-tests and chi-square analyses, the two treatment groups were demographically comparable. Using life-table analysis, no one therapeutic approach proved superior. Clomiphene citrate and PS are comparable treatment modalities in the setting of LPD given correction of endometrial lag.

Topics

luteal phase deficiency treatment, clomiphene citrate lpd, progesterone suppositories infertility, luteal phase support protocols, endometrial biopsy luteal phase, clomiphene vs progesterone lpd, vaginal progesterone luteal defect, luteal phase dysfunction correction, infertility luteal support comparison, endometrial lag treatment options, progesterone supplementation pregnancy rates

Cite this article

Murray, D. L., Reich, L., & Adashi, E. Y. (1989). Oral clomiphene citrate and vaginal progesterone suppositories in the treatment of luteal phase dysfunction: a comparative study. *Fertility and sterility*, *51*(1), 35-41. https://doi.org/10.1016/s0015-0282(16)60424-7

Related articles